Related Experiment Video
Updated: Mar 27, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Unilateral Renal Denervation for Refractory Hypertension in Aortic Dissection
Xian-Geng Hou1, Jun-Shi Zhang2, Guang-Mei Hu2
1Hypertension Department, Cardiovascular Center, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China; Key Laboratory of Hypertension Research of Xinjiang Medical University, Urumqi, China; Key Laboratory of High Incidence Disease Research in Xingjiang (Xinjiang Medical University), Ministry of Education, Urumqi, China.
Backgroud:
Refractory hypertension in patients with aortic dissection represents an extreme therapeutic challenge, as these patients are typically excluded from renal denervation (RDN) trials due to prohibitive procedural risks.
Case Summary:
A 40-year-old man with refractory hypertension complicated by a chronic DeBakey Type III (Stanford Type B) aortic dissection and abdominal aortic aneurysm presented with blood pressure of 171/98 mm Hg despite quintuple therapy. Unilateral right-sided RDN was performed using a multielectrode catheter, delivering 24 ablation lesions. Postprocedure, systolic blood pressure decreased by 30 mm Hg, enabling discontinuation of 2 antihypertensive agents.
Discussion:
This case demonstrates that unilateral RDN is safe and effective in patients with extreme vascular lesions where bilateral RDN is not suitable. The marked blood pressure response suggests heightened sympathetic drive in this population.
Take-Home Message:
RDN is also feasible for patients with aortic dissection, and even unilateral RDN can achieve a blood pressure-lowering effect. These findings are hypothesis-generating and require prospective validation.
More Related Videos
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Direct Renin Inhibitors
Aortic Regurgitation III: Medical Management

